Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
- DOI
- 10.1080/10245332.2018.1444919
- Published
- 2018 Feb 27
- Container
- Hematology (Amsterdam, Netherlands)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/10245332.2018.1444919,
title = {Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.},
author = {Saydam G and Haznedaroglu IC and Kaynar L and Yavuz AS and Ali R and Guvenc B and Akay OM and Baslar Z and Ozbek U and Sonmez M and Aydin D and Pehlivan M and Undar B and Dagdas S and Ayyildiz O and Akkaynak DZ and Akin G and İlhan O},
year = {2018},
journal = {Hematology (Amsterdam, Netherlands)},
doi = {10.1080/10245332.2018.1444919},
url = {https://doi.org/10.1080/10245332.2018.1444919}
}RIS
TY - JOUR TI - Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase. AU - Saydam G AU - Haznedaroglu IC AU - Kaynar L AU - Yavuz AS AU - Ali R AU - Guvenc B AU - Akay OM AU - Baslar Z AU - Ozbek U AU - Sonmez M AU - Aydin D AU - Pehlivan M AU - Undar B AU - Dagdas S AU - Ayyildiz O AU - Akkaynak DZ AU - Akin G AU - İlhan O PY - 2018 JO - Hematology (Amsterdam, Netherlands) DO - 10.1080/10245332.2018.1444919 UR - https://doi.org/10.1080/10245332.2018.1444919 ER -
APA
G, S., IC, H., L, K., AS, Y., R, A., B, G., OM, A., Z, B., U, O., M, S., D, A., M, P., B, U., S, D., O, A., DZ, A., G, A., & O, İ. (2018). Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.. Hematology (Amsterdam, Netherlands). https://doi.org/10.1080/10245332.2018.1444919
Source records
- pubmed · retrieved 2026-09-25T13:17:45.965Z